scholarly journals Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries

2020 ◽  
Vol Volume 12 ◽  
pp. 423-433
Author(s):  
Edith Heintjes ◽  
Irene D Bezemer ◽  
Daniel Prieto-Alhambra ◽  
Elisabeth Smits ◽  
Helen P Booth ◽  
...  
Keyword(s):  
European Countries ◽  
Uncontrolled Hypertension ◽  
Risk Minimization ◽  
Additional Risk

scholarly journals Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study

Drug Safety ◽  
2018 ◽  
Vol 41 (8) ◽  
pp. 797-806 ◽  
Author(s):  
Wally Landsberg ◽  
Imad Al-Dakkak ◽  
Antonia Coppin-Renz ◽  
Uli Geis ◽  
Timothy Peters-Strickland ◽  
...  
Keyword(s):  
European Union ◽  
Effectiveness Evaluation ◽  
The European Union ◽  
Risk Minimization ◽  
Safety Study ◽  
Additional Risk

scholarly journals Patient Preferences for Rituximab Additional Risk Minimization Measures

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Kristyna Schneiderova ◽  
Nathalie Bere ◽  
Doris Irene Stenver ◽  
Sabine M. J. M. Straus
Keyword(s):  
Patient Preferences ◽  
Risk Minimization ◽  
Additional Risk

Measuring the impact of the 2012 European pharmacovigilance legislation on additional risk minimization measures

2018 ◽  
Vol 17 (10) ◽  
pp. 975-982 ◽  
Author(s):  
Reynold D. C. Francisca ◽  
Inge M. Zomerdijk ◽  
Miriam C. J. M. Sturkenboom ◽  
Sabine M. J. M. Straus
Keyword(s):  
Risk Minimization ◽  
Additional Risk ◽  
The Impact

Evaluation of the effectiveness of risk minimization measures for trimetazidine: A cross sectional joint PASS survey among physicians in selected European countries

2018 ◽  
Vol 27 (12) ◽  
pp. 1385-1392 ◽  
Author(s):  
Dorothea von Bredow ◽  
Massoud Toussi ◽  
Abdus Samad ◽  
Sigal Kaplan ◽  
Mónika Domahidy ◽  
...  
Keyword(s):  
European Countries ◽  
Risk Minimization ◽  
Cross Sectional

scholarly journals Effectiveness of Additional Risk Minimization Measures for Atezolizumab in the European Union

2021 ◽  
Author(s):  
Hina Patel ◽  
Thanh G. N. Ton ◽  
Jessica Davies ◽  
Simon Fear ◽  
Carolin Block ◽  
...  
Keyword(s):  
European Union ◽  
The European Union ◽  
Risk Minimization ◽  
Additional Risk

Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey

2019 ◽  
Vol 33 (2) ◽  
pp. 121-133 ◽  
Author(s):  
Joanna Lem ◽  
Muhammad Younus ◽  
Jalal A. Aram ◽  
Shahrzad Moosavi ◽  
Klaus Freivogel ◽  
...  
Keyword(s):  
Healthcare Professional ◽  
Lessons Learned ◽  
Risk Minimization ◽  
Additional Risk ◽  
The Eu

scholarly journals Ivabradine drug utilization study in five European countries: A multinational, retrospective, observational study to assess effectiveness of risk‐minimization measures

2019 ◽  
Vol 28 (11) ◽  
pp. 1470-1479
Author(s):  
Linda Salem ◽  
Alexandre Malouvier ◽  
Jon Blatchford ◽  
Elena Rivero‐Ferrer ◽  
Nicolas Deltour ◽  
...  
Keyword(s):  
Observational Study ◽  
Drug Utilization ◽  
European Countries ◽  
Retrospective Observational Study ◽  
Risk Minimization ◽  
Drug Utilization Study

Evaluation of the Implementation of Additional Risk Minimization Activities in Europe, the USA, and Japan

2019 ◽  
Vol 33 (5) ◽  
pp. 417-424
Author(s):  
Yuka Yasuoka ◽  
Masayuki Kaneko ◽  
Mamoru Narukawa
Keyword(s):  
Risk Minimization ◽  
Additional Risk ◽  
The Usa
Sign in / Sign up

Export Citation Format

Share Document